Ampio Pharmaceuticals
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9800 Pyramid Ct Ste 400, Englewood, Colo...Phone Number
(720) 437-6500Website
www.ampiopharma.comRevenue
$9.5 MillionStock Symbol
AMPEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the advancement of immunology-based therapies to treat common inflammatory conditions for which there are limited treatment options. Ampio's lead drug, Ampion, is backed by an extensive patent portfolio with intellectual property protection extending through 2037 and will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the Biologics Price Competition and Innovation Act (BPCIA).Explore more
Ampio Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ampio Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ampio Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Ampio Pharmaceuticals recently announced quarterly report
Check out if Ampio Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Ampio Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ampio Pharmaceuticals
Ampio Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ampio Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ampio Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Ampio Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ampio Pharmaceuticals
Compare insights from companies similar to Ampio Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ampio Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ampio Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ampio Pharmaceuticals.
Ampio Pharmaceuticals financials insights
Gather financial insights about Ampio Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Ampio Pharmaceuticals Tech Stack
A closer look at the technologies used by Ampio Pharmaceuticals
Most Recent Scoops
Pain Point
Lawsuits
Lateral Move
Executive Move
Lateral Move
New Hire
Executive Move
New Hire, Board of Directors
Lateral Move
Executive Move
Ampio Pharmaceuticals News & Media
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2023, which was filed on March 27, 2024 with the...Ampio Pharmaceuticals reaches settlement in principle in certain legal actions
Ampio Pharmaceuticals reaches settlements in principle for pending securities fraud class action and derivative actions, with costs covered by D&O...Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
ENGLEWOOD, Colo., Oct. 5, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that it has...Ampio Pharmaceuticals to Present at the Emerging Growth Conference
ENGLEWOOD, Colo., Sept. 26, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") a pre-revenue stage biopharmaceutical Company focused on development of a potential treatment for osteoarthritis as part of its OA.201 program, today announced that its CEO,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ampio Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the advancement of immunology-based therapies to treat common inflammatory conditions for which there are limited treatment options. Ampio's lead drug, Ampion, is backed by an extensive patent portfolio with intellectual property protection extending through 2037 and wi... Read More
